PsychedelicNewsBreaks

WednesdayNov 11, 2020 10:21 am

PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) Goes Public on Canada’s Next-Gen Stock Exchange

Cybin (NEO: CYBN), a leading Toronto-based biotech and life sciences company focused on psychedelic pharmaceutical therapies, today made its debut on the global public markets and is now trading on the NEO Exchange under the symbol “CYBN.” The company, which focuses on psychedelic drug development, unique delivery mechanisms, improved novel compounds and protocols, recently closed a C$45 million subscription receipt financing in relation to its reverse takeover transaction. This signified the largest subscription receipt financing in the Canadian psychedelic sector. “Today marks a meaningful milestone for our company, as our shares begin trading on the NEO Exchange under the ticker…

Continue Reading

FridayNov 06, 2020 11:16 am

PsychedelicNewsBreaks – CYBIN Inc. Completes Reverse Takeover Transaction

CYBIN (formerly Clarmin Explorations Inc.), a life sciences company initially focused on psychedelic pharmaceutical therapies, on Thursday announced it has completed its previously disclosed reverse takeover of Clarmin Explorations Inc. per the terms of an amalgamation agreement dated June 26, 2020, as amended on October 21, 2020. The agreement was among Cybin Corp., Clarmin and 2762898 Ontario Inc. (“SubCo”), a wholly-owned subsidiary of the company (the “reverse takeover”), in which the reverse takeover was completed by way of a “three-cornered” amalgamation pursuant to the provisions of the Business Corporations Act (Ontario). Through the reverse takeover, Cybin Corp. amalgamated with SubCo…

Continue Reading

ThursdayNov 05, 2020 10:24 am

PsychedelicNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) Commences CSE Trading

Pure Extracts Technologies (CSE: PULL), a plant-based extraction company focused on cannabis, hemp, and functional mushroom sectors, today announced that, effective immediately, the company’s stock has commenced trading on the Canadian Securities Exchange (“CSE”) under the symbol “PULL.” “There currently is a tremendous consumer demand for natural health products with the ability to immediately enhance our quality of life. With Health Canada officially granting Pure Extracts a Standard Processing License under the Cannabis Act, this has put us on a path to deliver full-spectrum oil products by the end of Q4, 2020,” PULL CEO Ben Nikolaevsky said in a recent…

Continue Reading

MondayNov 02, 2020 2:42 pm

PsychedelicNewsBreaks – Cybin Corp. Paves Path to Profitability with Health-Care Veteran at the Helm

Cybin Corp., a Canada-based, life-science company advancing psychedelic pharmaceuticals, recently announced the appointment of Doug Drysdale as its CEO (https://ibn.fm/UTTdr). Drysdale, named an Ernst and Young Entrepreneur of the Year in 2012, brings more than three decades of experience in the health-care sector and will continue to grow the company’s IP portfolio. “With his myriad of business accomplishments, Doug is the ideal leader for Cybin,” stated Cybin co-founder and COO Paul Glavine of the appointment. “We believe that his extensive health-care sector background and international company management skills will help Cybin strengthen partnerships, develop strategic alliances and expand our international…

Continue Reading

FridayOct 30, 2020 2:22 pm

PsychedelicNewsBreaks – Pure Extract Technologies Inc. Leveraging Growing Acceptance of ‘Nature’s Miniature Pharmaceutical Factories’

Pure Extract, a private, plant-based extraction company, is leveraging growing acceptance by mainstream science and the general public to further develop and commercialize functional and medicinal mushroom products on a global scale. World-renowned mycologist Paul Stamets describes mushrooms as “nature’s miniature pharmaceutical factories” (https://ibn.fm/wbYSa). Studied extensively for their various health benefits, current research suggests different varieties of mushrooms may help to improve memory (https://ibn.fm/KUHQ3), mental cognition (https://ibn.fm/dNuo4) and to alleviate the symptoms of depression (https://ibn.fm/YCMQK). Further, “Psychedelic” varieties such as psilocybin – or “magic mushrooms” – are increasingly being studied for possible medical benefits in treating depression, anxiety, PTSD, bipolar disorder, Alzheimer’s disease and…

Continue Reading

FridayOct 30, 2020 1:35 pm

PsychedelicNewsBreaks – Rritual Mushrooms Inc. Recognized at ECRM’s Whole Body & Mind Wellness Program

Rritual, a plant-based consumer wellness brand, was selected as runner up for the Buyers Choice Award at last week’s virtual ECRM program. According to an article on Business Wire, Rritual’s Reishi Relax Elixir was selected for the award among dozens of entries evaluated by retail buyers. “Retail buyers selected Rritual for the award because our packaging, design and formulation stood out amongst the dozens of products they evaluated,” said David Kerbel, CEO of Rritual. “Their stamp of approval on our product reinforces what we know: that Rritual products will capture the attention of shoppers on shelves and in e-comm, supporting…

Continue Reading

ThursdayOct 29, 2020 12:34 pm

PsychedelicNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF) Addresses Continuous Disclosure Review

Champignon Brands (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF) has provided an update on its efforts to resolve a continuous disclosure review that was issued earlier this year. Champignon is working closely with the British Columbia Securities Commission (“BCSC”) to coordinate the revocation of the cease trade order and hopes to provide information about a revocation of the order as soon as possible. In the update, the company noted that it has submitted all documentation requested by the BCSC in connection with the review of financial statements of AltMed Capital Corp. ("AltMed") for the period ended June 30, 2020. The purpose of the…

Continue Reading

TuesdayOct 27, 2020 1:58 pm

PsychedelicNewsBreaks – Rritual Mushrooms Inc.’s New Line of Elixirs Provides ‘Daily Dose’ with Powerful Benefits

Rritual, a plant-based consumer wellness brand, is positioning to take advantage of opportunity in the functional food and mushroom market with the fall launch of its innovative suite of premium functional mushroom and adaptogenic elixirs. “The health and wellness benefits of mushrooms and plant-based therapies are backed by decades of scientific research,” Dr. Mike Hart, president of Rritual, who also oversaw the development of the new line of products, stated of the launch (https://ibn.fm/bW2n6). “Rritual’s new line of elixirs embraces that research and provides consumers with an easy way to get a daily dose of the powerful effects.” To view…

Continue Reading

TuesdayOct 20, 2020 1:36 pm

PsychedelicNewsBreaks – Pure Extract Technologies Inc. Looks to Production of Highest-Quality FSO

Pure Extract, a private, plant-based extraction company, was recently awarded a Standard Processing License by Health Canada under the Cannabis Act. Following this significant milestone, Pure Extracts will now proceed with application to Health Canada for a Natural Health Products Site License at its purpose-built extraction facility while adhering to EU Good Manufacturing Practices (“GMP”). This will help to enable the company to extract its full spectrum oil (“FSO”) to the highest-possible quality. “We are thrilled to be commencing production in our new, EU-GMP compliant, purpose-built facility,” stated Pure Extracts founder and COO Doug Benville in a recent article discussing…

Continue Reading

TuesdayOct 20, 2020 1:13 pm

PsychedelicNewsBreaks – Why Rritual Mushrooms Inc. Is ‘One to Watch’

Rritual is a private company and premium brand in the emerging functional mushrooms market. The company is dedicated to helping people meet the demands of modern life with style and ease by enriching their diets through incorporating functional mushrooms, adaptogens and superfoods. Rritual manufactures premium plant-based products, with each featuring mindfully selected ingredients and designed to fit every lifestyle and meet the demands of customers with various needs. A recent article discussing the company reads, “Rritual recently announced the launch of its suite of premium functional mushroom and adaptogenic elixirs. These elixirs were developed by a leading team of scientists,…

Continue Reading